Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 1998

View Archived Issues

Fusion protein enables large-scale production of bioactive carbohydrates

Sugen and Taiho will jointly develop angiogenesis inhibitors

Amgen: Q2 1998 highlights

Phase III trial of Ampligen for the treatment of CFS now underway

French team discloses newly discovered 5-HT1A agonists

Antiviral/antitumor nucleoside derivatives in the pipeline at Yamasa Shoyu

Antitumor platinum complexes synthesized at SS Pharmaceutical

Yamanouchi reveals new Na+/H+ exchange inhibitors

cGMP PDE inhibitors in early development at Eisai

MorphoSys and DuPont Pharmaceuticals sign collaboration agreement

Endorex and UW-Madison will codevelop antitumor compounds

Antibacterial phenazine compounds revealed by Otsuka

Daiichi team identifies new antitumor taxanes

Anti-HIV agents, protease inhibitors, patented by DuPont Merck

Schering-Plough patents new tachykinin NK1/NK2 antagonists

Chiral aspects of the pharmacokinetics of flobufen: important implications for therapeutic use

Three studies confirm efficacy and safety of Chinese AD treatment agent

Known antiischemic agent demonstrates cognition-enhancing effects

HMN-1152, a smooth muscle relaxant with a novel mechanism of action

AU-006, a novel quinoline derivative with potent antiulcer activity

New compound for urinary incontinence poised to enter clinical testing at Recordati

Y-700, a new kind of xanthine oxidase inhibitor in development at Yoshitomi

Analben, a non-narcotic analgesic in phase II testing

Pharmacokinetics of SPK-843, a promising new antifungal agent

Muscle-relaxant activity of silperisone: comparison with lidocaine

First volunteers dosed with R.W. Johnson's new gpIIb/IIIa antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...